Bleeding episodes in “complete, staged” versus “culprit only” revascularisation in patients with multivessel disease and ST-segment elevation myocardial infarction: a DANAMI-3-PRIMULTI substudy

Golnaz Sadjadieh1*, MD; Thomas Engstrøm1, MD, DMSc; Steffen Helqvist1, MD, DMSc; Dan Eik Høfsten1, MD, PhD; Lars Køber1, MD, DMSc; Frants Pedersen1, MD, PhD; Peter Clemmensen2,3,4, MD, DMSc; Erik Jørgensen1, MD; Kari Saunamäki1, MD, DMSc; Hans-Henrik Tilsted5, MD; Henning Kelbæk6, MD, DMSc; Lene Holmvang1, MD, DMSc

1. Department of Cardiology, Rigshospitalet - Copenhagen University Hospital, Copenhagen, Denmark; 2. Herzzentrum Hamburg, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany; 3. Department of Medicine, Nykøbing F Hospital, Nykøbing F, Denmark; 4. Un

Aims: The aim of this study was to evaluate whether a staged in-hospital complete revascularisation strategy increases the risk of serious bleeding events in patients with ST-segment elev

Sign in to read and download the full article

Login Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

bleedingcomplete revascularisationmultivessel diseasestemi

Coronary interventionsSTEMILeft main and multivessel diseaseVascular access and bleedingVascular access and bleeding

Share on Facebook Share on Twitter Share on Linkedin

Read next article

Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial